跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets
Approved
化学药品
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets
GlaxoSmithKline Inc
🇨🇳 National Medical Products Administration
Approval Date
Aug 9, 2021
Approval ID
8DqlhAyPQCP
Company
GlaxoSmithKline Inc
Type
化学药品
Approval Details
Approval Id
8DqlhAyPQCP
Approval Number
国药准字HJ20170001
Generic Name
盐酸帕罗西汀肠溶缓释片
Generic Name En
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets
Brand Name
赛乐特
Drug Type
化学药品
Dosage Form
片剂
Strength
12.5mg[按帕罗西汀(C₁₉H₂₀FNO₃)计]
Reg Date
2021-08-09
Expired Date
2026-08-08
Company Name
GlaxoSmithKline Inc
Company Detail Path
/organization/glaxosmithkline-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 9, 2021
Approval ID
8DqlhAyPQCP
Type
化学药品
Back to NMPA Approvals
赛乐特 - NMPA Drug Approval Details